Tilg H - Search Results

1

How does the microbiome affect liver disease?

Tilg H, Grander C, Moschen AR. Tilg H, et al. Clin Liver Dis (Hoboken). 2016 Nov 30;8(5):123-126. doi: 10.1002/cld.586. eCollection 2016 Nov. Clin Liver Dis (Hoboken). 2016. PMID: 31041079 Free PMC article. Review. No abstract available.

2

Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting.

Kaser A, Ludwiczek O, Waldenberger P, Jaschke W, Vogel W, Tilg H. Kaser A, et al. Among authors: tilg h. Liver. 2002 Oct;22(5):380-7. doi: 10.1034/j.1600-0676.2002.01666.x. Liver. 2002. PMID: 12390473

3

Increased expression of CCL20 in human inflammatory bowel disease.

Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Mürzl E, Grasl E, Jasarevic Z, Romani N, Offner FA, Tilg H. Kaser A, et al. Among authors: tilg h. J Clin Immunol. 2004 Jan;24(1):74-85. doi: 10.1023/B:JOCI.0000018066.46279.6b. J Clin Immunol. 2004. PMID: 14997037

4

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.

Wolf AM, Wolf D, Rumpold H, Moschen AR, Kaser A, Obrist P, Fuchs D, Brandacher G, Winkler C, Geboes K, Rutgeerts P, Tilg H. Wolf AM, et al. Among authors: tilg h. Clin Immunol. 2004 Oct;113(1):47-55. doi: 10.1016/j.clim.2004.05.004. Clin Immunol. 2004. PMID: 15380529

5

Adiponectin and its receptors in non-alcoholic steatohepatitis.

Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, Pons-Romero F, Ebenbichler CF, Patsch JR, Tilg H. Kaser S, et al. Among authors: tilg h. Gut. 2005 Jan;54(1):117-21. doi: 10.1136/gut.2003.037010. Gut. 2005. PMID: 15591515 Free PMC article.

6

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.

Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H. Moschen AR, et al. Among authors: tilg h. Gut. 2005 Apr;54(4):479-87. doi: 10.1136/gut.2004.044370. Gut. 2005. PMID: 15753532 Free PMC article.

7

Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.

Kaser S, Moschen A, Kaser A, Ludwiczek O, Ebenbichler CF, Vogel W, Jaschke W, Patsch JR, Tilg H. Kaser S, et al. Among authors: tilg h. J Intern Med. 2005 Sep;258(3):274-80. doi: 10.1111/j.1365-2796.2005.01543.x. J Intern Med. 2005. PMID: 16115302 Free article.

8

Adiponectin and its receptors in patients with chronic hepatitis C.

Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, Clouston AD, Powell EE, Tilg H. Jonsson JR, et al. Among authors: tilg h. J Hepatol. 2005 Dec;43(6):929-36. doi: 10.1016/j.jhep.2005.05.030. Epub 2005 Jul 1. J Hepatol. 2005. PMID: 16139921

9

The RANKL/OPG system and bone mineral density in patients with chronic liver disease.

Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Mühllechner P, Habior A, Graziadei I, Vogel W, Tilg H. Moschen AR, et al. Among authors: tilg h. J Hepatol. 2005 Dec;43(6):973-83. doi: 10.1016/j.jhep.2005.05.034. Epub 2005 Jul 5. J Hepatol. 2005. PMID: 16143421

10

Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice.

Wolf AM, Wolf D, Avila MA, Moschen AR, Berasain C, Enrich B, Rumpold H, Tilg H. Wolf AM, et al. Among authors: tilg h. J Hepatol. 2006 Mar;44(3):537-43. doi: 10.1016/j.jhep.2005.08.019. Epub 2005 Sep 23. J Hepatol. 2006. PMID: 16310276 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

510 results

Search Page